Clinical Study Results
Where can I learn more about the study?
You can find more information about this study on the websites listed below. If a full report of the study results is available, it can also be found here.

- www.clinicaltrials.gov. Once you are on the website, type "NCT02685293" into the search box and click "Search".
- www.AstraZenecaClinicalTrials.com. Once you are on the website, type "PT003017" into the search box and click "Find a Study".

Full study title: A Randomized, Phase IIIb, Two-period, Double-blind, Two-treatment, Chronic-dosing (7 Days), Single-center Crossover Study to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease, Compared With Placebo

National Clinical Trial number: NCT02685293

AstraZeneca Protocol number: PT003017

Pearl Therapeutics, Inc., sponsored this study and has its headquarters in Morristown, NJ, USA.

The phone number for the AstraZeneca Information Center is +1-877-240-9479.

Thank you!

Clinical study participants belong to a large community of people who take part in clinical research around the world. They help researchers answer important health questions and find medical treatments for participants.

The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting patients for clinical studies, nor is it involved in conducting clinical studies.

CISCRP
One Liberty Square, Suite 1100 · Boston, MA 02109
1-877-MED-HERO · www.ciscrp.org